Order: Signal: Tickers:
Filters: 0    Descriptive       Fundamental       Technical       All   
Exchange Index Sector Industry Country
Market Cap. Dividend Yield Float Short Analyst Recom. Option/Short
Earnings Date Average Volume Relative Volume Current Volume Price
Target Price IPO Date Shares Outstanding Float  
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
Total: 66 #1
CompanyErasca, Inc.
Market Cap1.12BEPS (ttm)-1.32
P/E-EPS this Y-116.70%
Forward P/E-EPS next Y-8.60%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.86EPS Q/Q-24.90%
Dividend-Sales Q/Q-
Insider Own0.40%Inst Own79.00%
Insider Trans0.00%Inst Trans4.75%
Short Float14.95%EarningsAug 11/a
Analyst Recom1.80Target Price22.40
Avg Volume381.94K52W Range4.51 - 23.50
Sep-07-22 04:05PMErasca Presents Promising Preliminary Phase 1/1b Monotherapy Data for ERAS-007 ERK and ERAS-601 SHP2 Inhibitors Supporting Ongoing and Future Combination Trials GlobeNewswire
Aug-24-22 08:00AMErasca to Host R&D Day with KOL Dr. David Hong on Lead Clinical Programs ERAS-007 and ERAS-601 in Advanced Solid Tumors GlobeNewswire
Aug-23-22 09:55AMHere's Why Erasca, Inc. (ERAS) Looks Ripe for Bottom Fishing Zacks
Aug-23-22 08:00AMErasca and MD Anderson Announce Strategic Research and Development Collaboration in RAS/MAPK-Driven Cancers GlobeNewswire
Aug-19-22 09:55AMWall Street Analysts See an 111% Upside in Erasca, Inc. (ERAS): Can the Stock Really Move This High? Zacks
Aug-11-22 04:05PMErasca Reports Second Quarter 2022 Financial Results and Business Updates GlobeNewswire
Aug-08-22 09:29AMHere's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation Simply Wall St.
Aug-03-22 09:55AMWall Street Analysts Believe Erasca, Inc. (ERAS) Could Rally 244%: Here's is How to Trade Zacks
Jul-27-22 06:00PMErasca, Inc. (ERAS) Gains But Lags Market: What You Should Know Zacks
Jul-21-22 06:00PMErasca, Inc. (ERAS) Stock Sinks As Market Gains: What You Should Know Zacks
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.
TickerAGS [NYSE]
CompanyPlayAGS, Inc.
Market Cap277.46MEPS (ttm)-0.59
P/E-EPS this Y74.30%
Forward P/E36.24EPS next Y172.40%
PEG-EPS past 5Y24.00%
P/S0.97EPS next 5Y-
P/B7.69EPS Q/Q139.30%
Dividend-Sales Q/Q14.70%
Insider Own0.60%Inst Own88.40%
Insider Trans0.00%Inst Trans3.64%
Short Float2.81%EarningsAug 09/a
Analyst Recom2.10Target Price11.50
Avg Volume373.46K52W Range4.21 - 10.45
Sep-05-22 01:01PMThe Return Trends At PlayAGS (NYSE:AGS) Look Promising Simply Wall St.
Aug-16-22 06:33AMPlayAGS, Inc.'s (NYSE:AGS) Intrinsic Value Is Potentially 94% Above Its Share Price Simply Wall St.
Aug-15-22 07:50AMPlayAGS Shares Pop Premarket On Takeover Offer At 33% Premium Benzinga
Aug-15-22 03:56AMStarbucks, Turquoise Hill, Vroom Fall Premarket; PlayAGS Rises Investing.com
Aug-12-22 12:36PMExclusive-Inspired Entertainment in bid to buy slot machine maker PlayAGS - sources Reuters
Aug-08-22 06:15PMPlayAGS (AGS) Q2 Earnings and Revenues Surpass Estimates Zacks
Aug-02-22 10:00AMLight & Wonder (LNW) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
Aug-01-22 09:15AMAGS Moves Second Quarter 2022 Results Release Date to Monday, August 8, 2022 PR Newswire
Jul-19-22 09:15AMAGS to Report Second Quarter 2022 Results on Tuesday, August 9, 2022 PR Newswire
PlayAGS, Inc. designs and supplies gaming products and services for the gaming industry in the United States and internationally. It operates through three segments: Electronic Gaming Machines (EGM), Table Products, and Interactive Games (Interactive). The EGM segment offers various video slot titles for the marketplace; and EGM cabinets, including the Orion Starwall, Orion Curve Premium, Big Red, Orion Portrait, Orion Slant, Orion Curve, Orion Upright, and ICON. This segment also provides conversion kits that allow existing game titles to be converted to other game titles offered within that operating platform. It serves Class II Native American and Mexico, as well as Class III Native American, commercial, and charitable jurisdictions. The Table Products segment offers table products, including live felt table games, side bet offerings, progressives, card shufflers, signage, and other ancillary table game equipment, as well as table technology related to blackjack, poker, baccarat, craps, and roulette. This segment also provides Dex S, a single deck card shuffler for poker tables. Its brands include In Bet, Buster Blackjack, Double Draw Poker, and Criss Cross Poker. The Interactive segment offers a platform for business-to-business content aggregation used by real-money gaming and sports-betting partners; and business-to-consumer social casino games through its mobile app, Lucky Play Casino. The company was formerly known as AP Gaming Holdco, Inc. and changed its name to PlayAGS, Inc. in December 2017. PlayAGS, Inc. was incorporated in 2005 and is headquartered in Las Vegas, Nevada.
CompanyWheeler Real Estate Investment Trust, Inc.
IndustryREIT - Retail
Market Cap15.33MEPS (ttm)-1.41
P/E-EPS this Y-42.40%
Forward P/E-EPS next Y-
PEG-EPS past 5Y7.30%
P/S0.25EPS next 5Y-
P/B-EPS Q/Q49.80%
Dividend-Sales Q/Q0.00%
Insider Own1.60%Inst Own28.00%
Insider Trans-43.92%Inst Trans-2.26%
Short Float0.25%Earnings-
Analyst Recom-Target Price-
Avg Volume83.51K52W Range1.51 - 3.39
Aug-22-22 04:15PMWheeler Real Estate Investment Trust, Inc. and Cedar Realty Trust, Inc. Announce Completion of Merger ACCESSWIRE
Aug-09-22 04:20PMWheeler Real Estate Investment Trust, Inc. Announces Second Quarter 2022 Financial and Operating Results ACCESSWIRE
May-11-22 04:20PMWheeler Real Estate Investment Trust, Inc. Announces First Quarter 2022 Financial And Operating Results ACCESSWIRE
May-09-22 06:45AMGreat news for Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR): Insiders acquired stock in large numbers last year Simply Wall St.
Nov-18-21 01:19PMMultiple insiders bought Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) stock earlier this year, a positive sign for shareholders Simply Wall St.
Nov-15-21 12:16PMAlluvial Capital Remains Optimistic in Wheeler Real Estate (WHLR) Despite Negative Returns Insider Monkey
Headquartered in Virginia Beach, VA, Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR ) is a fully integrated, self-managed commercial real estate investment company focused on owning and operating income-producing retail properties with a primary focus on grocery-anchored centers.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campbell Kerry G.DirectorSep 06Sale2.2376,890171,4653,000Sep 07 05:07 PM
Campbell Kerry G.DirectorAug 30Sale2.0220,11040,62279,890Aug 31 05:00 PM
CompanyBiophytis S.A.
Market Cap17.85MEPS (ttm)-2.61
P/E-EPS this Y37.90%
Forward P/E-EPS next Y-
PEG-EPS past 5Y27.10%
P/S-EPS next 5Y-
P/B2.47EPS Q/Q61.60%
Dividend-Sales Q/Q-
Insider Own-Inst Own1.00%
Insider Trans-Inst Trans-23.36%
Short Float-Earnings-
Analyst Recom2.00Target Price15.00
Avg Volume162.63K52W Range0.81 - 9.59
Sep-07-22 07:05AMBiophytis Shares Surge After Promising Data From COVID-19 Treatment Study Benzinga
Sep-07-22 02:20AMBiophytis Announces Very Promising Top Line Results of its Phase 2-3 COVA Clinical Study in COVID-19-Related Respiratory Failure ACCESSWIRE
Jun-30-22 05:20PMBiophytis Announces the Drawing of the Second Tranche of Ornane Under the 2021 Atlas Contract for 4 Million ACCESSWIRE
Jun-27-22 05:45PMBiophytis Presents the Development of Sarconeos (BIO101) in Phase 3 for the Treatment of Sarcopenia at the 15th SCWD International Congress ACCESSWIRE
Jun-22-22 05:30PMBiophytis: Results of the Combined General Meeting on June 21, 2022 ACCESSWIRE
Jun-03-22 05:20PMBiophytis: Convening of Another Combined General Meeting at a Later Date ACCESSWIRE
May-12-22 02:20AMBiophytis: Biophytis Announces its Participation at the BIO International Convention in San Diego from the 13th to the 16th of June ACCESSWIRE
Apr-19-22 02:20AMBiophytis: Biophytis Presents Sarconeos (BIO101) Development Program in Sarcopenia at the 12th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) in Boston April 20-22, 2022 ACCESSWIRE
Apr-07-22 08:11AMBiophytis Shares Fall As It Stops Enrollment In Sarconeos COVID-19 Trial, Data Expected In Q3 2022 Benzinga
Apr-07-22 02:25AMBiophytis Provides Updates on Sarconeos (BIO101) Clinical Development ACCESSWIRE
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.
CompanySpero Therapeutics, Inc.
Market Cap52.52MEPS (ttm)-3.48
P/E-EPS this Y17.50%
Forward P/E-EPS next Y34.10%
PEG-EPS past 5Y-6.20%
P/S5.31EPS next 5Y36.90%
P/B1.31EPS Q/Q-39.00%
Dividend-Sales Q/Q-60.80%
Insider Own16.03%Inst Own59.40%
Insider Trans1.86%Inst Trans3.23%
Short Float1.38%EarningsAug 10/a
Analyst Recom2.50Target Price9.75
Avg Volume2.46M52W Range0.68 - 19.87
Sep-07-22 12:37PMBiotech Stock Roundup: GILD's Updates, FMTX Up on NVO Deal, SPRO Surges & More Zacks
Sep-07-22 10:36AMSpero (SPRO) Up Following Positive FDA Update for UTI Drug Zacks
Sep-07-22 08:05AMSpero Therapeutics to Present at Upcoming Investor Conference GlobeNewswire
Sep-06-22 10:10AMSpero Therapeutics Shares Jump After Upbeat FDA Feedback For Tebipenem HBr Program Benzinga
Sep-06-22 08:05AMSpero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration GlobeNewswire
Sep-05-22 06:49AMCan Spero Therapeutics (NASDAQ:SPRO) Afford To Invest In Growth? Simply Wall St.
Aug-25-22 09:55AMSpero Therapeutics, Inc. (SPRO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Zacks
Aug-10-22 05:25PMSpero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates Zacks
Aug-10-22 04:05PMSpero Therapeutics Announces Second Quarter 2022 Operating Results and Provides Business Update GlobeNewswire
Aug-09-22 08:05AMSpero Therapeutics to Provide Business Update and Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022 GlobeNewswire
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shukla SathChief Financial OfficerAug 29Sale0.896,0175,37856,064Aug 30 05:00 PM
Aquilo Capital Management, LLC10% OwnerApr 26Buy5.2439,727207,9715,321,231Apr 28 04:13 PM
Aquilo Capital Management, LLC10% OwnerMar 30Buy8.7950,000439,4205,281,504Mar 31 03:51 PM
Aquilo Capital Management, LLC10% OwnerMar 14Buy7.6323,708180,7975,231,504Mar 16 04:23 PM
Aquilo Capital Management, LLC10% OwnerFeb 28Buy9.5344,833427,2275,207,796Mar 02 03:52 PM
TickerCTV [NYSE]
CompanyInnovid Corp.
IndustryAdvertising Agencies
Market Cap506.37MEPS (ttm)0.77
P/E4.77EPS this Y-991.10%
Forward P/E-EPS next Y40.00%
PEG-EPS past 5Y-
P/S4.67EPS next 5Y-
P/B2.30EPS Q/Q102.30%
Dividend-Sales Q/Q45.20%
Insider Own4.80%Inst Own63.00%
Insider Trans0.00%Inst Trans4.96%
Short Float0.87%EarningsAug 10/b
Analyst Recom2.00Target Price5.67
Avg Volume322.49K52W Range1.62 - 10.00
Aug-30-22 04:30PMInnovid to Present at Evercore's 2nd Annual Technology Conference on September 7, 2022 PR Newswire
Aug-13-22 08:31AMInnovid Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year Simply Wall St.
Aug-10-22 07:00AMInnovid Reports Second Quarter 2022 Financial Results PR Newswire
Jul-21-22 08:30AMInnovid to Announce Second Quarter 2022 Financial Results on August 10th, 2022 PR Newswire
Jul-15-22 06:17AMWhat Kind Of Investors Own Most Of Innovid Corp. (NYSE:CTV)? Simply Wall St.
Jul-11-22 07:30AMInnovid to Present at Upcoming July Investor Events on July 12, 2022 PR Newswire
Jul-08-22 07:30AMInnovid Announces Changes to its Board of Directors PR Newswire
Jun-22-22 07:59AMThe past year for Innovid (NYSE:CTV) investors has not been profitable Simply Wall St.
Jun-07-22 07:30AMInnovid to Participate in MKM Virtual Ad-Tech Summit PR Newswire
Jun-03-22 08:30AMAdImpact Partners with Innovid to Measure Political TV Advertising Across Linear & CTV Business Wire
Innovid Corp. operates an independent software platform that provides ad serving and creative services. The company offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. It also provides creative management; advertising measurement; identity resolution; and publisher solutions. The company serves consumer packaged goods, pharmaceutical and healthcare, financial services, and automotive and technology industries; third party agencies; and publishers in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Innovid Corp. was incorporated in 2007 and is headquartered in New York, New York.
CompanyBilibili Inc.
IndustryElectronic Gaming & Multimedia
Market Cap9.70BEPS (ttm)-3.03
P/E-EPS this Y-105.20%
Forward P/E-EPS next Y31.00%
PEG-EPS past 5Y-33.20%
P/S3.26EPS next 5Y-
P/B3.30EPS Q/Q-128.00%
Dividend-Sales Q/Q29.60%
Insider Own3.27%Inst Own31.60%
Insider Trans0.00%Inst Trans-15.97%
Short Float9.93%EarningsSep 08/b
Analyst Recom1.80Target Price41.25
Avg Volume5.39M52W Range14.93 - 89.80
Sep-08-22 07:55AMBilibili (BILI) Reports Q2 Loss, Tops Revenue Estimates Zacks
Sep-08-22 06:50AMBilibili stock dives after wider-than-expected loss, downbeat revenue outlook MarketWatch
Sep-08-22 06:30AMBilibili Inc. Announces Second Quarter 2022 Financial Results GlobeNewswire
Sep-06-22 10:38AMBillionaire Ray Dalio Is Selling These 10 Tech Stocks Insider Monkey
Sep-01-22 03:14PMTencent Targets About $14.5 Billion in Divestments, FT Says Bloomberg
Aug-26-22 04:32AMChina Tech Stocks Gain as Talks Progress to Avoid US Delistings Bloomberg
Aug-25-22 03:40PMWhy Pinduoduo, Bilibili, and Huya Rocketed Higher Today Motley Fool
Aug-25-22 03:39PMWhy Bilibili, Baidu, and New Oriental Education Stocks Rallied This Week Motley Fool
Aug-25-22 08:00AMChinese Stocks in US Jump as New Stimulus Lifts Investor Mood Bloomberg
Aug-19-22 09:12AM10 Best Affordable Tech Stocks to Invest In Now Insider Monkey
Bilibili Inc. provides online entertainment services for the young generations in the People's Republic of China. Its platform offers a range of content, including video services, mobile games, and value-added service, as well as ACG-related comic and audio content. The company's video services include professional user generated videos, occupationally generated videos, and live broadcasting. Bilibili Inc. was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.
CompanyGraphex Group Limited
CountryHong Kong
IndustryOther Industrial Metals & Mining
Market Cap63.41MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.17EPS next 5Y-
P/B0.15EPS Q/Q-
Dividend-Sales Q/Q-10.70%
Insider Own-Inst Own0.01%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume2.00M52W Range1.50 - 4.66
Aug-31-22 07:01AMGraphex Group Announces Interim Financial Highlights and Global Expansion Progress GlobeNewswire
Aug-26-22 04:15PMGraphex Group Limited Announces Full Exercise of Over-Allotment Option in Underwritten Public Offering GlobeNewswire
Aug-22-22 09:29AMGraphex Technologies Highlights U.S. Expansion Progress and Outlines Business Strategy GlobeNewswire
Aug-19-22 04:05PMGraphex Group Limited Announces Closing of Upsized $11.7 Million Public Offering and NYSE American Listing GlobeNewswire
Aug-16-22 07:08PMGraphex Group Limited Announces Pricing of Upsized $11.7 Million Public Offering and NYSE American Listing GlobeNewswire
Graphex Group Limited engages in the development, manufacturing, and marketing of graphene products in the People's Republic of China. The company operates through three segments: Manufacturing and Sale of Graphene Products; Landscape Design; and Catering. It provides natural spherical graphite to produce anodes for Li-ion batteries used in electric vehicles; high purity graphite for use in refractory materials and advanced coatings, and other products; and synthetic graphite. The company also offers landscape architecture services and activities. In addition, it provides catering and interior design and landscape architecture services; and invests in food industry; and focuses on the operation of restaurants. The company was formerly known as Earthasia International Holdings Limited and changed its name to Graphex Group Limited in April 2021. Graphex Group Limited was founded in 1981 and is headquartered in Causeway Bay, Hong Kong.
CompanySidus Space, Inc.
IndustryAerospace & Defense
Market Cap49.14MEPS (ttm)-0.17
P/E-EPS this Y20.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S16.08EPS next 5Y-
Dividend-Sales Q/Q1075.00%
Insider Own-Inst Own2.40%
Insider Trans-Inst Trans-
Short Float3.97%Earnings-
Analyst Recom-Target Price7.50
Avg Volume6.75M52W Range1.26 - 29.70
Sep-07-22 09:00AMSidus Space Executes Multiple Launch Agreement with SpaceX Business Wire
Sep-06-22 04:00PMSidus Space to Present at H.C. Wainwright 24th Annual Global Investment Conference Business Wire
Aug-26-22 09:00AMSidus Space Celebrates Vital Role in NASAs Historic Artemis I Mission Business Wire
Aug-23-22 09:00AMSidus Space Signs MOU with Exo-Space to Support Edge Computing Technology Business Wire
Aug-18-22 09:30AMTaglich Brothers Initiates Coverage of Sidus Space, Inc. GlobeNewswire
Aug-16-22 03:00PMSidoti's August Micro-Cap Virtual Conference ACCESSWIRE
Aug-12-22 07:00AMSidus Space, Inc. Reports Second Quarter 2022 Results and Business Update Business Wire
Aug-10-22 09:00AMSidus Space to Present at Sidoti Microcap Virtual Investor Conference, August 18 at 9:15 a.m. ET Business Wire
Aug-05-22 09:00AMSidus Space Schedules Second Quarter 2022 Earnings Release and Business Update Webcast Business Wire
Aug-02-22 09:00AMSidus Space Selects AWS for LizzieSatTM Constellation Business Wire
Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its services include satellite manufacturing; precision manufacturing, assembly, and test; low earth orbit microsatellite; payload integrations; launch and support services; space-based data services and analytics; precision computer numerical control machining and fabrication; Swiss screw machining; wire cable harness fabrication; 3D composite and metal printing; and satellite deployment and microgravity testing and research services, as well as services related to electrical and electronic assemblies. The company also offers hardware solutions consisting of an external flight test platform to develop, test, and fly experiments, as well as delivers hardware, materials, and advanced electronics on the international space station; and space station integrated kinetic launcher for orbital payload systems. It serves commercial space, aerospace, defense, underwater marine, and other commercial and government customers. The company was founded in 2014 and is headquartered in Merritt Island, Florida. Sidus Space, Inc. is a subsidiary of Craig Technical Consulting, Inc.
CompanyMasterCraft Boat Holdings, Inc.
IndustryRecreational Vehicles
Market Cap432.25MEPS (ttm)3.36
P/E7.06EPS this Y330.90%
Forward P/E4.88EPS next Y13.66%
PEG0.71EPS past 5Y39.60%
P/S0.67EPS next 5Y10.00%
P/B3.20EPS Q/Q22.40%
Dividend-Sales Q/Q26.20%
Insider Own2.30%Inst Own92.10%
Insider Trans0.00%Inst Trans-0.39%
Short Float3.32%EarningsSep 08/b
Analyst Recom2.20Target Price34.60
Avg Volume84.15K52W Range20.25 - 29.69
Sep-08-22 07:30AMMasterCraft Boat Holdings, Inc. Reports Record Fourth Quarter and Fiscal 2022 Results GlobeNewswire
Sep-08-22 07:00AMMasterCraft Boat Holdings, Inc. Sells NauticStar Business to Iconic Marine Group GlobeNewswire
Aug-19-22 01:41PMMasterCraft Boat Holdings, Inc. to Webcast Fiscal Fourth Quarter and Full Year 2022 Earnings Conference Call Thursday, September 8, 2022 GlobeNewswire
Aug-09-22 04:30PMMasterCraft Boat Holdings, Inc. Announces Review of Strategic Alternatives for NauticStar Business GlobeNewswire
Aug-07-22 08:15AMAre Strong Financial Prospects The Force That Is Driving The Momentum In MasterCraft Boat Holdings, Inc.'s NASDAQ:MCFT) Stock? Simply Wall St.
Jul-07-22 11:55AMMasterCraft Makes Summer Better With Release of New Model and Features for 2023 GlobeNewswire
Jun-22-22 11:00AMMasterCraft Adds All-New XT22 T to the XT Lineup, Amplifying On-Water Traditions GlobeNewswire
May-30-22 06:46AMThose who invested in MasterCraft Boat Holdings (NASDAQ:MCFT) five years ago are up 22% Simply Wall St.
May-24-22 01:33PMMasterCraft Brings More Guts to Its Lineup With New MY23 XStar S Piranha Limited Edition GlobeNewswire
May-12-22 09:00AMMasterCraft Signs Award-Winning Wakeboarder, Tyler Higham GlobeNewswire
MasterCraft Boat Holdings, Inc., through its subsidiaries, designs, manufactures, and markets recreational powerboats. It operates through three segments: MasterCraft, NauticStar, and Crest. The MasterCraft segment produces recreational performance sport boats and luxury day boats under the MasterCraft and Aviara brands, which are used for water skiing, wakeboarding, and wake surfing, as well as general recreational boating. The NauticStar segment offers boats that are primarily used for saltwater fishing and general recreational boating. The Crest segment produces pontoon boats for use in general recreational boating. The company also offers ski/wake, outboard, and sterndrive boats, as well as various accessories, including trailers and aftermarket parts. It sells its boats under the MasterCraft, NauticStar, Crest, and Aviara brands through a network of independent dealers in North America and internationally. The company was formerly known as MCBC Holdings, Inc. and changed its name to MasterCraft Boat Holdings, Inc. in November 2018. MasterCraft Boat Holdings, Inc. was founded in 1968 and is based in Vonore, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campion Donald CDirectorOct 18Sale26.474,641122,84713,246Oct 19 04:23 PM
Campion Donald CDirectorOct 12Sale26.462,06954,74617,887Oct 13 04:05 PM
Campion Donald CDirectorOct 11Sale26.402,84475,08219,956Oct 12 04:08 PM